ILIBRIFT Trademark

Trademark Overview

On Monday, June 30, 2008, a trademark application was filed for ILIBRIFT with the United States Patent and Trademark Office. The USPTO has given the ILIBRIFT trademark a serial number of 79055888. The federal status of this trademark filing is IR CANCELLED - US REGISTRATION CANCELLED as of Sunday, July 1, 2018. This trademark is owned by SANOFI-AVENTIS. The ILIBRIFT trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical goods, namely, preparations for the prevention and treatment of cardiovascular diseases; pharmaceutical goods, namely, preparations for the prevention and treatment of cancer; pharmaceutical goods, namely, preparations for the prevention and treatment of thrombosis; pharmaceutical goods, namely, preparations for the prevention and treatment of diseases in the field of internal medicine, namely, pharmaceutical preparations for the treatment of infectious diseases; pharmaceutical goods, namely, preparations for the prevention and treatment of diseases of the central nervous system; pharmaceutical goods, namely, preparations for the prevention and treatment respiratory diseases
ilibrift

General Information

Serial Number79055888
Word MarkILIBRIFT
Filing DateMonday, June 30, 2008
Status404 - IR CANCELLED - US REGISTRATION CANCELLED
Status DateSunday, July 1, 2018
Registration Number3602809
Registration DateTuesday, April 7, 2009
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, January 20, 2009

Trademark Statements

Goods and ServicesPharmaceutical goods, namely, preparations for the prevention and treatment of cardiovascular diseases; pharmaceutical goods, namely, preparations for the prevention and treatment of cancer; pharmaceutical goods, namely, preparations for the prevention and treatment of thrombosis; pharmaceutical goods, namely, preparations for the prevention and treatment of diseases in the field of internal medicine, namely, pharmaceutical preparations for the treatment of infectious diseases; pharmaceutical goods, namely, preparations for the prevention and treatment of diseases of the central nervous system; pharmaceutical goods, namely, preparations for the prevention and treatment respiratory diseases
Translation of Words in MarkThe mark "ILIBRIFT" has no meaning in a foreign language.

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status CodeF - NOT AVAILABLE
Class Status DateFriday, November 13, 2015
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameSANOFI
Party Type30 - Original Registrant
Legal Entity Type99 - Other
AddressFR
Party NameSANOFI-AVENTIS
Party Type20 - Owner at Publication
Legal Entity Type99 - Other
AddressFR
Party NameSANOFI-AVENTIS
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressFR

Trademark Events

Event DateEvent Description
Friday, February 22, 2019UNDELIVERABLE MAIL - NO ACTION TAKEN
Friday, January 25, 2019NOTIFICATION OF EFFECT OF CANCELLATION OF INTL REG MAILED
Friday, January 25, 2019DEATH OF INTERNATIONAL REGISTRATION
Friday, April 21, 2017TOTAL INVALIDATION PROCESSED BY THE IB
Thursday, July 14, 2016TOTAL INVALIDATION OF REG EXT PROTECTION SENT TO IB
Thursday, July 14, 2016INVALIDATION PROCESSED
Wednesday, July 13, 2016TOTAL INVALIDATION OF REG EXT PROTECTION CREATED
Friday, November 13, 2015CANCELLED SECTION 71
Monday, April 15, 2013FINAL DECISION TRANSACTION PROCESSED BY IB
Saturday, July 21, 2012CHANGE OF NAME/ADDRESS REC'D FROM IB
Saturday, December 10, 2011CHANGE OF NAME/ADDRESS REC'D FROM IB
Monday, July 27, 2009FINAL DISPOSITION NOTICE SENT TO IB
Monday, July 27, 2009FINAL DISPOSITION PROCESSED
Wednesday, July 8, 2009FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Tuesday, April 7, 2009REGISTERED-PRINCIPAL REGISTER
Tuesday, January 20, 2009PUBLISHED FOR OPPOSITION
Wednesday, December 31, 2008NOTICE OF PUBLICATION
Wednesday, December 17, 2008LAW OFFICE PUBLICATION REVIEW COMPLETED
Wednesday, December 17, 2008APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, December 16, 2008TEAS/EMAIL CORRESPONDENCE ENTERED
Tuesday, December 16, 2008CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, December 16, 2008ASSIGNED TO LIE
Tuesday, December 2, 2008TEAS CHANGE OF CORRESPONDENCE RECEIVED
Tuesday, December 2, 2008TEAS RESPONSE TO OFFICE ACTION RECEIVED
Tuesday, December 2, 2008ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Tuesday, December 2, 2008TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Friday, October 3, 2008REFUSAL PROCESSED BY IB
Tuesday, September 9, 2008NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Tuesday, September 9, 2008REFUSAL PROCESSED BY MPU
Tuesday, September 9, 2008NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Monday, September 8, 2008NON-FINAL ACTION WRITTEN
Friday, September 5, 2008ASSIGNED TO EXAMINER
Monday, August 11, 2008NEW APPLICATION ENTERED IN TRAM
Friday, August 8, 2008LIMITATION OF GOODS/SERVICES FROM IB ENTERED
Thursday, August 7, 2008SN ASSIGNED FOR SECT 66A APPL FROM IB

Related Keywords

ilibrift pharmaceutical preparations treatment namely goods prevention diseases central nervous system